Kenya: Early adopter of low-cost PCV

Home > Kenya: Early adopter of low-cost PCV
  • PresenterRose Jalang'o, NVIP Kenya
  • EventIHEA 2025 pre-congress
  • LanguageEnglish

ROSE JALANG’O, NVIP Kenya

eddah.rose@gmail.com

Dr. Rose Jalang’o is Head of Kenya’s National Vaccines and Immunization Program, specializing in vaccinology, global health leadership, and sustainable immunization financing. She has led the introduction and nationwide roll-out of vaccines including HPV, Yellow Fever, Meningitis, COVID-19, Typhoid, and Measles-Rubella, combining strategic planning, data-driven policy, and resource mobilization to strengthen Kenya’s immunization systems. She holds an MBChB, an MPH, and advanced training in vaccinology and biomedical research.

Learn more about IHEA 2025

Click the links below to navigate to our IHEA 2025 presentations or our general resource library where you can sort all our resources based on presenter, organizational affiliation, topic, and more.